Dr. Il Je Yu's research links human environmental exposure to toxicology, specializing in inhalation toxicology with occupational toxicology, nanotoxicology, safe chemical management and industrial hygiene, including exposure assessment.
Specific research objectives include contributing to assessing risks of nanoparticles and hazardous inhalants such as fumes, dust, organic solvents and chemicals; managing research centers and setting exposure limits; and developing new occupational and environmental toxicology programs. I have published more than 230 articles in international scientific journals and have led seven projects of international standard development in the ISO TC 229 (Nanotechnology) and conducted several projects for OECD WPMN and EU NanoREG. I was involved in developing WHO Guidelines on Nanomaterials and Workers’ Health and the WHO/IPCS Environmental Health Criteria Document on Principles and Methods for assessing the risk of immunotoxicity associated with exposure to nanomaterials. I served as a working group member for IARC monograph 93 (carbon black, titanium dioxide and talc); 111 (carbon nanotubes, fluoro-edenite and silicon carbide); and 133 (anthracene, 2-bromopropane, butyl methacrylate and dimethyl hydrogen phosphite). In addition, my current works include developing methods of nanomaterial toxicokinetics after inhalation exposure with animal welfare consideration and in vitro inhalation toxicity testing device development for laboratory toxicity study as well as field monitoring study.
I provide equal opportunities for all students and participants regardless of their background or identity. I welcome people of all backgrounds to apply. I invest in training and education to increase awareness and understanding of equity, diversity and inclusion among our students.
Partnership with H&H Bio in Korea and HCT America (San Jose)
